Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | €116.80B | 14.3x | -0.52 | €93.14 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.3% Upside | Upgrade to Pro+ | |
EssilorLuxottica | Paris | Healthcare | Healthcare Equipment & Supplies | €106.16B | 45.7x | -13.29 | €232.30 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.1% Downside | Upgrade to Pro+ | |
Sartorius Stedim | Paris | Healthcare | Healthcare Equipment & Supplies | €17.91B | 109.5x | -1.71 | €184.25 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Biomerieux | Paris | Healthcare | Healthcare Equipment & Supplies | €12.12B | 29.4x | 4.34 | €102.40 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Eurofins Scientific | Paris | Healthcare | Healthcare Providers & Services | €9.37B | 33.3x | -1.41 | €48.54 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.1% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | €9.06B | 13.4x | 0.27 | €110.20 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.9% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | €2.62B | 18.6x | 0.97 | €314.50 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Ramsay Generale De Sante | Paris | Healthcare | Healthcare Providers & Services | €1.34B | -24.8x | 0.11 | €12.10 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emeis | Paris | Healthcare | Healthcare Providers & Services | €944.46M | 0.3x | 0.01 | €5.83 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vetoquinol | Paris | Healthcare | Pharmaceuticals | €899.27M | 19.1x | -0.98 | €75.90 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.3% Upside | Upgrade to Pro+ | |
Clariane SE | Paris | Healthcare | Healthcare Providers & Services | €716.85M | -0x | 0 | €2.05 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.7% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | €489.88M | -15.6x | 1.8 | €16.80 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.2% Upside | Upgrade to Pro+ | |
Boiron | Paris | Healthcare | Pharmaceuticals | €463.57M | 19.6x | -0.39 | €26.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.7% Upside | Upgrade to Pro+ | |
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €427.52M | -2.2x | -1.43 | €6.70 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €340.65M | -38.9x | -0.5 | €2.10 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guerbet | Paris | Healthcare | Healthcare Equipment & Supplies | €335.40M | 10.2x | 0.06 | €26.50 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Euroapi | Paris | Healthcare | Pharmaceuticals | €267.69M | -1.3x | 0 | €2.81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.8% Upside | Upgrade to Pro+ | |
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €254.61M | 42.2x | -1.71 | €25.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.3% Upside | Upgrade to Pro+ | |
LNA Sante SA | Paris | Healthcare | Healthcare Providers & Services | €246.43M | 10.2x | €24.10 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | ||
Lumibird SA | Paris | Healthcare | Healthcare Equipment & Supplies | €208.11M | 32x | -1.01 | €9.46 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29% Upside | Upgrade to Pro+ | |
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €191.03M | -6x | -0.12 | €0.64 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €190.70M | -1x | 0.21 | €2.19 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €182.96M | 8.2x | 0.05 | €3.51 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bastide Le Confort | Paris | Healthcare | Healthcare Providers & Services | €177.58M | -200.4x | -0.22 | €24.35 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44% Upside | Upgrade to Pro+ | |
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €155.75M | 3.3x | 0.01 | €7.16 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €154.14M | -1.5x | -0.05 | €1.58 | 8.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplitude Surgical SAS | Paris | Healthcare | Healthcare Equipment & Supplies | €151.59M | 98.8x | -1.02 | €3.16 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €142.67M | -4.6x | -0.1 | €1.94 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €140.79M | -3.8x | -0.08 | €2.94 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €111.07M | -3.7x | 0.1 | €8.02 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |